Bio-IT World coming to Berlin in October
“Bringing Bio-IT World Conference & Expo to Berlin this Fall helps us expand our European footprint, which already includes our well-established Bioprocessing Summit Europe, PEGS Europe, SCOPE Europe and Immuno-Oncology Summit Europe events.” said Phillips Kuhl, CEO, and Founder of CHI.
NEEDHAM, Mass. (PRWEB)
September 28, 2022
The Bio-IT World Conference & Expo, the premier event showcasing applications of IT and informatics to biomedical research and the drug discovery enterprise, proudly announces its European event taking place 18-19 October 2022 in Berlin, Germany. The Bio-IT World Conference & Expo Europe builds on the strong success of the Bio-IT World Conference & Expo that has been taking place for over twenty years in Boston, Mass.
“Having a more robust European presence is essential to the success of CHI. Bringing Bio-IT World Conference & Expo to Berlin this Fall will help us expand our European footprint, which already includes our well-established Bioprocessing Summit Europe, PEGS Europe, SCOPE Europe and Immuno-Oncology Summit Europe events. To produce the Europe event, CHI draws upon the expertise of those who have been organizing the U.S.-based event and our extensive relationships with experts and key advisors in Europe. The long-term plan is to maintain the U.S. event during the Spring in Boston, Massachusetts, and the European event in the Fall,” said Phillips Kuhl, CEO, and Founder of CHI.
The Bio-IT World Conference & Expo Europe will feature 60+ distinguished speakers who will share their expertise across five conference tracks (R&D in Pharma; AI for Pharma; Storage Infrastructure and Cloud Computing; Data Management, and Bioinformatics); a stellar plenary keynote program exploring themes of artificial intelligence, digital twins, and data strategies; an exhibit hall featuring companies displaying innovative technologies and solutions; and networking opportunities across two days with senior level informatics experts and IT professionals from pharma, biotechnology and academia from around the world. If attendees can’t participate join us in Berlin—or if they want to revisit presentations from the event—programming will be available on-demand after the event.
“We are thrilled to bring the Bio-IT World Conference & Expo to Europe.” said Cindy Crowninshield, RDN, LDN, Executive Event Director for Bio-IT World. “Our Event Team has produced a formidable program that will bring together a community of people across Europe to discuss new trends in data generation, knowledge management, and information technology in life sciences and drug development, including best practice case studies and joint partner presentations relevant to the technologies, research, and regulatory issues of life science, pharmaceutical, clinical and IT professionals.”
For more information or to register, visit http://www.Bio-ITWorldEurope.com
About Bio-IT World Conference & Expo
For over 20 years, the Bio-IT World Conference & Expo has been the world’s premier event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Bio-IT World unites a community of leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts in the field of biomedical research, drug discovery & development, and healthcare from around the world.
About Cambridge Healthtech Institute – Your Life Science Network
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Barnett Educational Services, Cambridge Meeting Planners and Healthtech Publishing, which includes publications such as Bio-IT World, Clinical Informatics News, and Diagnostics World, as well as numerous e-newsletters.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with a heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. The executive team has a combined 170+ years of experience and drives the CHI portfolio to deliver cutting-edge information and the most up-to-date research.
Share article on social media or email: